Fettucciari K, Dini F, Marconi P, Bassotti G
Biology (Basel). 2023; 12(8).
PMID: 37627001
PMC: 10452684.
DOI: 10.3390/biology12081117.
Marquardt I, Jakob J, Scheibel J, Hofmann J, Klawonn F, Neumann-Schaal M
Front Microbiol. 2022; 12:752549.
PMID: 34992584
PMC: 8727052.
DOI: 10.3389/fmicb.2021.752549.
Melhem H, Regan-Komito D, Hendrik Niess J
Int J Mol Sci. 2021; 22(24).
PMID: 34948435
PMC: 8707880.
DOI: 10.3390/ijms222413642.
Fradrich C, Beer L, Gerhard R
Toxins (Basel). 2016; 8(1).
PMID: 26797634
PMC: 4728547.
DOI: 10.3390/toxins8010025.
Clare-Pascoe N, Lee M, Murphy T, Nicholson A, Ferguson T
West Indian Med J. 2015; 64(4):413-8.
PMID: 26624597
PMC: 4909078.
DOI: 10.7727/wimj.2014.180.
High temporal resolution of glucosyltransferase dependent and independent effects of Clostridium difficile toxins across multiple cell types.
DAuria K, Bloom M, Reyes Y, Gray M, Van Opstal E, Papin J
BMC Microbiol. 2015; 15:7.
PMID: 25648517
PMC: 4323251.
DOI: 10.1186/s12866-015-0361-4.
Elevated lactoferrin is associated with moderate to severe Clostridium difficile disease, stool toxin, and 027 infection.
Boone J, DiPersio J, Tan M, Salstrom S, Wickham K, Carman R
Eur J Clin Microbiol Infect Dis. 2013; 32(12):1517-23.
PMID: 23771554
PMC: 3825630.
DOI: 10.1007/s10096-013-1905-x.
The enterotoxicity of Clostridium difficile toxins.
Sun X, Savidge T, Feng H
Toxins (Basel). 2011; 2(7):1848-80.
PMID: 22069662
PMC: 3153265.
DOI: 10.3390/toxins2071848.
Clostridium difficile toxin A decreases acetylation of tubulin, leading to microtubule depolymerization through activation of histone deacetylase 6, and this mediates acute inflammation.
Nam H, Kang J, Kim S, Ahn K, Seok H, Park S
J Biol Chem. 2010; 285(43):32888-32896.
PMID: 20696758
PMC: 2963380.
DOI: 10.1074/jbc.M110.162743.
Recognition and prevention of hospital-associated enteric infections in the intensive care unit.
Bobo L, Dubberke E
Crit Care Med. 2010; 38(8 Suppl):S324-34.
PMID: 20647790
PMC: 3657464.
DOI: 10.1097/CCM.0b013e3181e69f05.
Clostridium difficile infection in the intensive care unit.
Riddle D, Dubberke E
Infect Dis Clin North Am. 2009; 23(3):727-43.
PMID: 19665092
PMC: 2726831.
DOI: 10.1016/j.idc.2009.04.011.
Clostridium difficile-associated disease in children with solid tumors.
Castagnola E, Battaglia T, Bandettini R, Caviglia I, Baldelli I, Nantron M
Support Care Cancer. 2008; 17(3):321-4.
PMID: 18802726
DOI: 10.1007/s00520-008-0507-0.
Glutamine depletion potentiates leucocyte-dependent inflammatory events induced by carrageenan or Clostridium difficile toxin A in rats.
Nascimento S, Sousa R, Martins M, Gomes A, Souza M, Guerrant R
Immunology. 2005; 116(3):328-36.
PMID: 16236122
PMC: 1802418.
DOI: 10.1111/j.1365-2567.2005.02232.x.
Clostridium difficile toxins: mechanism of action and role in disease.
Voth D, Ballard J
Clin Microbiol Rev. 2005; 18(2):247-63.
PMID: 15831824
PMC: 1082799.
DOI: 10.1128/CMR.18.2.247-263.2005.
Update on Clostridium difficile infection.
Alcantara C, Guerrant R
Curr Gastroenterol Rep. 2000; 2(4):310-4.
PMID: 10981029
DOI: 10.1007/s11894-000-0024-x.
Serum antitoxin antibodies mediate systemic and mucosal protection from Clostridium difficile disease in hamsters.
Giannasca P, Zhang Z, Lei W, Boden J, Giel M, Monath T
Infect Immun. 1999; 67(2):527-38.
PMID: 9916055
PMC: 96351.
DOI: 10.1128/IAI.67.2.527-538.1999.
Effects of toxin A from Clostridium difficile on mast cell activation and survival.
Calderon G, Torres-Lopez J, Lin T, Chavez B, Hernandez M, Munoz O
Infect Immun. 1998; 66(6):2755-61.
PMID: 9596744
PMC: 108266.
DOI: 10.1128/IAI.66.6.2755-2761.1998.
Antibodies to recombinant Clostridium difficile toxins A and B are an effective treatment and prevent relapse of C. difficile-associated disease in a hamster model of infection.
Kink J, Williams J
Infect Immun. 1998; 66(5):2018-25.
PMID: 9573084
PMC: 108158.
DOI: 10.1128/IAI.66.5.2018-2025.1998.
The involvement of macrophage-derived tumour necrosis factor and lipoxygenase products on the neutrophil recruitment induced by Clostridium difficile toxin B.
Souza M, Melo-Filho A, Rocha M, Lyerly D, Cunha F, Lima A
Immunology. 1997; 91(2):281-8.
PMID: 9227329
PMC: 1363859.
DOI: 10.1046/j.1365-2567.1997.00243.x.
Clostridium difficile toxin A induces the release of neutrophil chemotactic factors from rat peritoneal macrophages: role of interleukin-1beta, tumor necrosis factor alpha, and leukotrienes.
Rocha M, Maia M, Bezerra L, Lyerly D, Guerrant R, Ribeiro R
Infect Immun. 1997; 65(7):2740-6.
PMID: 9199444
PMC: 175386.
DOI: 10.1128/iai.65.7.2740-2746.1997.